HuGE Literature Finder
Records
1
-
2
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung cancer (Amsterdam, Netherlands) 2010 May 68 (2): 234-9. Jatoi Aminah, Ritter Howard L, Dueck Amylou, Nguyen Phuong L, Nikcevich Daniel A, Luyun Ronnie F, Mattar Bassam I, Loprinzi Charles |
Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Molecular genetics and metabolism 0 86 (1-2): 293-9. Meirhaeghe Aline, Cottel Dominique, Amouyel Philippe, Dallongeville Je |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: